Argus
•
Oct 28, 2026
RVTY: Raising target price to $170.00
Summary
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Veralto Corporation
Oct 30, 2026
•
VLTO
Analyst Report: Thermo Fisher Scientific Inc
Oct 30, 2026
•
TMO
Market Digest: AMZN, TT, KLAC, LLY, LMT, MSFT, PSA, TMO, MA, AGNC, HLT, STRL
Oct 30, 2026
•
MSFT, KLAC, TT, HLT, LMT, MA, AGNC, TMO, LLY, STRL, AMZN, PSA
Analyst Report: West Pharmaceutical Services, Inc.
Oct 29, 2026
•
WST
Analyst Report: IDEX Corp
Oct 29, 2026
•
IEX
